Evidence map›Paper›PMID 27569560›Full record

ArticleCellular & molecular immunology2017

CD4 and CD8 T cells mediate distinct lethal meningoencephalitis in mice challenged with Tacaribe arenavirus.

Derek Dc Ireland, Cecilia Tami, Joao Pedras-Vasconcelos, Daniela Verthelyi

Open access · hybridAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Bystander activated CD8Nature communications · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. PD1Virologica Sinica · 2019
    Article
  7. Article
  8. Review
  9. Innate immunity and inflammation.Cellular & molecular immunology · 2017
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Derek Dc IrelandDivision of Biologics Review and Research-III, Office of Biotechnology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Cecilia TamiDivision of Biologics Review and Research-III, Office of Biotechnology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Joao Pedras-VasconcelosDivision of Biologics Review and Research-III, Office of Biotechnology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Daniela VerthelyiDivision of Biologics Review and Research-III, Office of Biotechnology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Center for Drug Evaluation and Research · USCenter for Biologics Evaluation and Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonates are at increased risk of viral encephalopathies that can result in neurological dysfunction, seizures, permanent disability and even death. The neurological damage results from the combined effect of the virus and the immune response it elicits, thus finding tools to facilitate viral clearance from central nervous system (CNS) while minimizing neuron damage remains a critical challenge. Neonatal mice inoculated intraperitoneally with Tacaribe virus (TCRV) develop seizures, hindlimb paralysis and death within 15 days of inoculation. TCRV localizes to the CNS within days of challenge, primarily infecting astrocytes in the cerebellum and brain stem. We show that infection leads to inflammation, T cell and monocyte infiltration into the cerebellar parenchyma, apoptosis of astrocytes, neuronal degeneration and loss of Purkinje cells. Infiltrating antigen-specific T cells fail to clear the virus but drive the disease, as T-cell-deficient CD3ɛ KO mice survive TCRV infection with minimal inflammation or clinical manifestations despite no difference in CNS viral loads in comparison with T-cell sufficient mice. CD8+ T cells drive the pathology, which even in the absence of CD4+ T-cell help, infiltrate the parenchyma and mediate the apoptotic loss of cerebellar astrocytes, neurodegeneration and loss of Purkinje cells resulting in loss of balance, paralysis and death. CD4+ T cells are also pathogenic inducing gliosis and inflammation in the cerebellum and cerebrum that are associated with wasting and death several weeks after CD4+ T-cell transfer. These data demonstrate distinct pathogenic effects of CD4+ and CD8+ T cells and identify them as possible therapeutic targets.

Indexed as

AnimalsAnimals, NewbornApoptosisArenaviridae InfectionsArenavirusAstrocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCentral Nervous SystemGliosisMeningoencephalitisMice, Inbred C57BLMice, TransgenicMicrogliaNerve DegenerationNeurons

Identifiers

PMID27569560
PMCPMC5214944
OpenAlexW2507642282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.